共 40 条
[4]
Blay JY, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00254-5
[6]
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)
[J].
ANNALS OF ONCOLOGY,
2021, 32 (04)
:533-541